Key result
Triglyceride self-monitoring in Type 2 diabetes reveals large individual variation despite strong overall correlation.
Why the study?
Little is known about the variability of fasting and postprandial triglyceride concentrations in day-to-day life in Type 2 diabetic patients.
Observational (n=24)
Effect estimate: r = 0.925
p-value: p=< 0.001
There is large intra- and inter-individual variability in fasting and postprandial triglyceride concentrations in Type 2 diabetic patients, which should be considered before initiating pharmacological therapy for hypertriglyceridemia.
Large TG variability in T2DM cautions against single measurements before therapy; leaves open optimal monitoring strategies.
Triglycerides are an important risk factor for coronary heart disease in Type 2 (non-insulin-dependent) diabetes mellitus. Although Type 2 diabetic patients have an exaggerated postprandial triglyceride response to a fat meal test, little is known about the variability of triglyceride concentrations in day-to-day life. We have studied the variability in triglyceride concentrations in 24 Type 2 diabetic patients over 6 months by having them record fasting and postprandial triglyceride concentrations at home using a Reflotron dry chemistry analyser. All patients were able to use the analyser effectively, with a correlation of 0.97 between patients' monthly Reflotron readings and those recorded by the laboratory. Over 1600 measurements were performed. The results demonstrate a large variation in both fasting (median 1.95 mmol l-1, range 0.8-6.7 mmol l-1) and postprandial triglyceride concentrations (median 2.68 mmol l-1, range 0.8-6.7 mmol l-1). This variation was accounted for by both a large intra- and inter-individual variation. Although there was a strong correlation overall between fasting and postprandial triglyceride concentrations r = 0.925 (p < 0.001), this did not apply on an individual basis. In conclusion, the large variability in triglyceride concentrations should be considered before introducing pharmacological therapy for hypertriglyceridaemia in Type 2 diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (1996) conducted an observational in Type 2 diabetes mellitus (n=24). Self-monitoring of triglycerides was evaluated on Variability in fasting and postprandial triglyceride concentrations (r = 0.925, p=< 0.001). Self-monitoring of triglycerides in Type 2 diabetes revealed large intra- and inter-individual variation in fasting and postprandial levels, despite a strong overall correlation (r=0.925, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: